BIOSYNEX (ALBIO.PA) Stock Income Statement
EPA:ALBIO - Euronext Paris - Matif - FR0011005933 - Common Stock - Currency: EUR
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 101.17M | 92.98M | 196.60M | 382.50M | 153.90M | |||
| Minority Interest Expense | 64.00K | -176.00K | 0.00 | N/A | N/A | |||
| Cost Of Goods | 43.75M | 43.85M | 94.30M | 176.10M | 84.60M | |||
| Gross Profit | 57.42M | 49.13M | 102.30M | 206.40M | 69.30M | |||
| Operating Expenses | 93.75M | 86.54M | 63.40M | 65.80M | 23.90M | |||
| Selling, General, and Administrative Expenses | 42.44M | 37.01M | 57.00M | 58.10M | 31.70M | |||
| Operating Income | -36.33M | -37.40M | 38.80M | 140.60M | 45.40M | |||
| Interest Income/Expense | -3.03M | -2.08M | -400.00K | -300.00K | 100.00K | |||
| Other Income/Expense | -3.19M | -982.00K | -2.80M | 400.00K | -300.00K | |||
| Non Recurring Items | -1.53M | 2.28M | -5.90M | -1.00M | -700.00K | |||
| Income Before Taxes | -44.65M | -38.16M | 29.80M | 139.60M | 44.40M | |||
| Income Tax | -1.35M | -2.56M | 8.60M | 32.90M | 12.10M | |||
| Net Income | -43.33M | -37.12M | 15.60M | 104.00M | 31.40M | |||
| EBITDA | -15.80M | -23.95M | 65.70M | 142.60M | 52.60M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -3.33 | -2.94 | 1.52 | 9.36 | 3.43 | |||
| Statistics | ||||||||
| Gross Profit Margin | 56.76% | 52.84% | 52.03% | 53.96% | 45.03% | |||
| Profit Margin | -42.83% | -39.93% | 7.93% | 27.19% | 20.40% | |||
| Operating Profit Margin | -35.91% | -40.23% | 19.74% | 36.76% | 29.50% | |||
All data in EUR